CN1387889A - Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis - Google Patents
Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis Download PDFInfo
- Publication number
- CN1387889A CN1387889A CN 02113187 CN02113187A CN1387889A CN 1387889 A CN1387889 A CN 1387889A CN 02113187 CN02113187 CN 02113187 CN 02113187 A CN02113187 A CN 02113187A CN 1387889 A CN1387889 A CN 1387889A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- atrophic gastritis
- spleen
- gastritis
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to Chinese medicine compounding technology and aims at providing one Chinese medicine preparation for treating spleen and stomach Yin-deficiency type atrophic gastritis in obvious curative effect and less toxic side effect. The Chinese medicine preparation has the material composition including Codonopsis Pilosulae, dry organe peel, Chinese yam, ginger, figwort and other six kinds of Chinese medicinal material. It is in two forms of capsule and granule. It has obvious treating effect to chronic superficial gastritis and atrophic gastritis.
Description
Technical field: the invention belongs to the Chinese medicine complex preparation, particularly a kind of Chinese medicine preparation for the treatment of deficiency of spleen and stomach Yin type atrophic gastritis.
Background technology: atrophic gastritis is a kind of of chronic gastritis, because the conversion ratio of its gastric cancer is higher, so often be counted as the cercinoma prophase pathologic change of gastric cancer.Therefore, atrophic gastritis is the disease of a kind of serious harm health and safety.According to the theory of the traditional Chinese medical science " dialectical executing controlled, YIN and YANG in a relative equilibrium ", but the atrophic gastritis medicine typing is deficiency of spleen and stomach Yang type and deficiency of spleen and stomach Yin type.The tcm diagnosis standard of deficiency of spleen and stomach Yin type atrophic gastritis is: type of deficiency of stomach yin stomachache, burning pain in the epigastrium, xerostomia happiness are cold, appetite stimulator, constipation with dry stool, upset in the stomach, few, the thready pulse of red tongue tongue.At present, the medicine that is used for the treatment of chronic gastritis is a lot, as MOLUO DAN, WEIFUCHUN, SANJIU WEITAI etc., though all have certain curative effect, do not control because it carries out the medicine typing opinion, so be difficult to suit the remedy to the case, therefore, its therapeutic effect is not quite desirable, and curative effect is not high.
Summary of the invention: technical problem to be solved by this invention is: according to the traditional Chinese medical science " dialectical medication ", the theory of " suiting the remedy to the case ", chronic gastritis is carried out medicine typing opinion control, a kind of Chinese medicine preparation of evident in efficacy, the stable and treatment deficiency of spleen and stomach Yin type atrophic gastritis that has no side effect is provided.
Its technical scheme is: a kind of Chinese medicine preparation for the treatment of deficiency of spleen and stomach Yin type atrophic gastritis is characterized in that its raw material components percentage by weight is:
Radix Codonopsis 5-15 Pericarpium Citri Reticulatae 4-12 Rhizoma Dioscoreae 5-15 Rhizoma Zingiberis 1-5
Radix Scrophulariae 5-15 Fructus Mume 7-16 Radix Glehniae 5-15 Rhizoma Polygonati (steaming) 5-15
The Rhizoma Atractylodis Macrocephalae (stir-fry) 5-15 Fructus Crataegi (stir-fry) 5-15 field dobber (decocting a drug wrapped) 5-15
Radix Codonopsis, Rhizoma Dioscoreae, Rhizoma Polygonati QI invigorating are set upright and are principal agent in the side, and the regulating immunological function microcirculation improvement is repaired gastric mucosa, and the atrophy body of gland is had restitution.The Rhizoma Atractylodis Macrocephalae can anti-helicobacter pylori, suppresses bile reflux, strengthens the merit of holding up the spleen stomach reinforcing.Fructus Mume, Fructus Crataegi are promoted the production of body fluid aid digestion, two-ways regulation gastric acid secretion function.The hot-tempered product of Radix Scrophulariae, Radix Glehniae, field dobber isothermal form nourishing YIN can supplementing QI and nourishing YIN.
This preparation is production technology routinely, can make two kinds of dosage forms of capsule and electuary respectively, so that take.
This preparation has the merit of anti-inflammatory and antalgic, stomach reinforcing QI invigorating, strengthening the body resistance; gastric mucosa and anti-gastric mucosa injury had tangible reparation, protective effect; the gastritis model that freund adjuvant is caused has therapeutical effect preferably; lesion degrees such as gastric mucosal erosion, chronic inflammation cellular infiltration, hyperemia are alleviated or the incidence rate minimizing; alleviate and recover the atrophy of gastric gland body, improve stomach and secrete acid, facilitating digestion liquid and digestive enzyme secretion; strengthen gastric motility, strengthen and recovery immunity.
Be the patient of deficiency of spleen and stomach Yin type chronic superficial gastritis and atrophic gastritis through 60 examples are clarified a diagnosis, be divided into two groups at random, take capsule and electuary (its dosage and contain the crude drug amount suitable) respectively.Capsules group 30 examples, wherein atrophic gastritis 16 examples have 6 examples to observe half a year, superficial gastritis 14 examples; The oldest 62 years old, minimum 24 years old; The course of disease is the shortest 10 months, and is the longest 20 years, electuary group 30 examples, and wherein atrophic gastritis 15 examples have 7 examples to observe half a year, superficial gastritis 15 examples; The oldest 61 years old, minimum 26 years old, the course of disease is the shortest 6 months, and was the longest 14 years.Its symptom total effects sees Table 1.
Table 1
The example number | Produce effects | Effectively | Invalid | Total effective rate (%) | |
Capsules group electuary group | ????30 | ????6 | ????20 | ????4 | ????86.67 |
????30 | ????5 | ????21 | ????4 | ????86.67 |
Its sick curative effect of planting sees Table 2.Table 2
Superficial gastritis | Atrophic gastritis | |||||
Two months | Two months | Six months | ||||
Capsules group | The electuary group | Capsules group | The electuary group | Capsules group | The electuary group | |
The example number | ????14 | ????15 | ????16 | ????15 | ????6 | ????7 |
Produce effects | ????3 | ????3 | ????3 | ????2 | ????2 | ????1 |
Effectively | ????10 | ????10 | ????10 | ????11 | ????3 | ????5 |
Invalid | ????1 | ????2 | ????3 | ????2 | ????1 | ????1 |
Total effective rate (%) | ????92.85 | ????86.67 | ????81.25 | ????86.67 | ????83.33 | ????85.71 |
Its cardinal symptom curative effect sees Table 3.Table 3
The example number | Produce effects | Effectively | Invalid | Total effective rate (%) | ||
Gastric cardialgia | The electuary group | 29 | ?11 | ?14 | ????4 | ??86.21 |
Capsules group | 30 | ?13 | ?14 | ????3 | ??90 | |
Desire for cold drinks | The electuary group | 22 | ?8 | ?10 | ????4 | ??81.82 |
Capsules group | 23 | ?10 | ?10 | ????3 | ??86.96 | |
Dry mouth and tougue | The electuary group | 26 | ?10 | ?13 | ????3 | ??88.46 |
Capsules group | 27 | ?13 | ?10 | ????4 | ??85.19 | |
Feverish sensation in the palms and soles | The electuary group | 20 | ?8 | ?9 | ????3 | ??85 |
Capsules group | 20 | ?10 | ?8 | ????2 | ??90 |
Its gastroscopy effect sees Table 4.Table 4
Superficial gastritis | Atrophic gastritis | |||||
Two months | Two months | Six months | ||||
Capsules group | The electuary group | Capsules group | The electuary group | Capsules group | The electuary group | |
The example number | ????14 | ????15 | ????16 | ????15 | ????6 | ????7 |
Produce effects | ????3 | ????3 | ????1 | ????2 | ????1 | |
Effectively | ????9 | ????9 | ????10 | ????7 | ????4 | ????4 |
Invalid | ????2 | ????3 | ????5 | ????6 | ????2 | ????2 |
Total effective rate (%) | ????85.71 | ????80 | ????71.42 | ????68.75 | ????66.67 | ????71.42 |
Through clinical observation more than a year, this preparation is not found side effect, and check routine blood test, liver, renal function etc. do not find that it has infringement to important organs such as the blood system heart, Liver and kidney before and after the treatment.Check table 5 is seen in its safety.
Table 5
The unusual case load of Capsules group | The unusual case load of electuary group | |||
Before the treatment | After the treatment | Before the treatment | After the treatment | |
??HB | ????0 | ????0 | ????0 | ????0 |
??WBC | ????0 | ????0 | ????0 | ????0 |
??RBC | ????0 | ????0 | ????0 | ????0 |
??SGPT | ????0 | ????0 | ????0 | ????0 |
??RUN | ????0 | ????0 | ????0 | ????0 |
??CR | ????0 | ????0 | ????0 | ????0 |
??OB | ????0 | ????0 | ????0 | ????0 |
In sum, this Chinese medicine preparation, no matter be capsule or electuary, treatment YIN-deficiency type chronic superficial gastritis and atrophic gastritis all there are definite curative effect and significant effect, clinical application is extensive, safety, and having no side effect, the curative effect proper extension of YIN-deficiency type atrophic gastritis is more helped to improve curative effect its course of treatment, is the important breakthrough of treatment by Chinese herbs atrophic gastritis.
Embodiment:
Embodiment 1: get Radix Codonopsis 5Kg, Rhizoma Dioscoreae 15kg, Rhizoma Polygonati (steaming) 15kg, Pericarpium Citri Reticulatae 4kg, Rhizoma Zingiberis 1kg, Radix Scrophulariae 5kg, Fructus Mume 16kg, Radix Glehniae 5kg, the Rhizoma Atractylodis Macrocephalae (stir-fry) 5kg, Fructus Crataegi (stir-fry) 5kg, field dobber (decocting a drug wrapped) 5kg.
Production technology is made capsule or electuary dosage form routinely.
Embodiment 2: get Radix Codonopsis 10kg, Rhizoma Dioscoreae 10kg, Rhizoma Polygonati (steaming) 10kg, Pericarpium Citri Reticulatae 8kg, Rhizoma Zingiberis 3kg, Radix Scrophulariae 10kg, Fructus Mume 12kg, Radix Glehniae 10kg, the Rhizoma Atractylodis Macrocephalae (stir-fry) 10kg, Fructus Crataegi (stir-fry) 10kg, field dobber (decocting a drug wrapped) 10kg, production technology is made capsule or electuary dosage form routinely.
Embodiment 3: get Radix Codonopsis 15kg, Rhizoma Dioscoreae 5kg, Rhizoma Polygonati (steaming) 5kg, Pericarpium Citri Reticulatae 12kg, Rhizoma Zingiberis 4kg, Radix Scrophulariae 15kg, Fructus Mume 7kg, Radix Glehniae 15kg, the Rhizoma Atractylodis Macrocephalae (stir-fry) 15kg, Fructus Crataegi (stir-fry) 15kg, field dobber (decocting a drug wrapped) 15kg, connect conventional production process and make capsule or electuary dosage form.
Claims (2)
1, a kind of Chinese medicine preparation for the treatment of deficiency of spleen and stomach Yin type atrophic gastritis is characterized in that its raw material components percentage by weight is:
Radix Codonopsis 5-15 Pericarpium Citri Reticulatae 4-12 Rhizoma Dioscoreae 5-15 Rhizoma Zingiberis 1-5
Radix Scrophulariae 5-15 Fructus Mume 7-16 Radix Glehniae 5-15 Rhizoma Polygonati (steaming) 5-15
The Rhizoma Atractylodis Macrocephalae (stir-fry) 5-15 Fructus Crataegi (stir-fry) 5-15 field dobber (decocting a drug wrapped) 5-15
2,, it is characterized in that described preparation is capsule and two kinds of dosage forms of electuary as weighing 1 described a kind of Chinese medicine preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02113187 CN1242800C (en) | 2002-06-15 | 2002-06-15 | Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02113187 CN1242800C (en) | 2002-06-15 | 2002-06-15 | Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1387889A true CN1387889A (en) | 2003-01-01 |
CN1242800C CN1242800C (en) | 2006-02-22 |
Family
ID=4742493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02113187 Ceased CN1242800C (en) | 2002-06-15 | 2002-06-15 | Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1242800C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102824549A (en) * | 2012-09-24 | 2012-12-19 | 周国生 | Traditional Chinese medicine for treating stomach-Yin deficiency |
CN103157076A (en) * | 2011-12-13 | 2013-06-19 | 韩兴霞 | Traditional Chinese medicine preparation for treatment of chronic gastritis |
CN105435202A (en) * | 2016-01-05 | 2016-03-30 | 段希福 | Medicinal preparation for treating gastritis and purpose thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103989957A (en) * | 2014-05-14 | 2014-08-20 | 张华� | Pharmaceutical composition for treating stomach-yin deficiency type chronic gastritis and preparation method thereof |
-
2002
- 2002-06-15 CN CN 02113187 patent/CN1242800C/en not_active Ceased
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103157076A (en) * | 2011-12-13 | 2013-06-19 | 韩兴霞 | Traditional Chinese medicine preparation for treatment of chronic gastritis |
CN102824549A (en) * | 2012-09-24 | 2012-12-19 | 周国生 | Traditional Chinese medicine for treating stomach-Yin deficiency |
CN102824549B (en) * | 2012-09-24 | 2014-05-07 | 南阳医学高等专科学校 | Traditional Chinese medicine for treating stomach-Yin deficiency |
CN105435202A (en) * | 2016-01-05 | 2016-03-30 | 段希福 | Medicinal preparation for treating gastritis and purpose thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1242800C (en) | 2006-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103405701A (en) | Medicine for treating gastrointestinal diseases and preparation method thereof | |
CN102078462A (en) | Asthma relieving medicament | |
CN102488846B (en) | Medicinal composition for treating diabetes mellitus | |
CN102210818B (en) | Chinese medicine for treating gastrorrhagia | |
CN1213760C (en) | Chinese medicine prepn for treating deficiency of spleen and stomach Yang type atrophic gastritis | |
CN100553673C (en) | The Chinese patent medicine of treatment chronic pharyngitis | |
CN1367003A (en) | Medicine for curing AIDS | |
CN101874850B (en) | Medicament for treating chronic urticaria | |
CN1242800C (en) | Chinese medicine prepn for treating deficiency of spleen and stomach Yin type atrophic gastritis | |
CN111588757A (en) | Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease in stable phase and preparation method thereof | |
CN103479947B (en) | The preparation method of control constipation medicine | |
CN103751745A (en) | Traditional Chinese medicine for treating urticaria | |
CN101979061A (en) | Antiemetic medicine | |
CN1207021C (en) | Chinese patent medicine for curing gastropathy | |
CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
CN102836407B (en) | Medicament for treating chronic colitis | |
CN101979056A (en) | Traditional Chinese medicament for treating asthma | |
CN102824461A (en) | Medicine for treating hypertension and preparation method thereof | |
CN107582831A (en) | It is a kind of effectively to alleviate gaseous distention and the Chinese medicine composition of hiccup | |
CN113230379B (en) | Qi-regulating and lump-relieving decoction for treating gastroparesis syndrome after abdominal tumor surgery | |
CN101766745A (en) | Medicine for treating gastritis and preparation method | |
CN100540043C (en) | A kind of treatment hypertension drug | |
CN107773625A (en) | A kind of relieving cough and asthma Chinese medicinal decoction | |
CN104127557A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
CN106822515A (en) | One kind treats the dyspeptic Traditional chinese medicine medicament formula of liver-stomach disharmony type |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Xuan Shengyi Document name: Notification to Pay the Fees |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060222 Termination date: 20100615 |
|
C35 | Partial or whole invalidation of patent or utility model | ||
IW01 | Full invalidation of patent right |
Decision date of declaring invalidation: 20101215 Decision number of declaring invalidation: 15735 Granted publication date: 20060222 |